Crossmark

Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans

Crossref DOI link: https://doi.org/10.1136/bmjresp-2014-000032

Published Online: 2014-06-30

Published Print: 2014-06

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Shofer, Scott

Beyea, Matthew

Li, Sufeng

Bastian, Lori A

Wahidi, Momen M

Kelley, Michael

Lipkus, Isaac M
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01038492 at ClinicalTrials.gov

Documents that mention this clinical trial

Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans
https://doi.org/10.1136/bmjresp-2014-000032